References
- Bushrab FN, Muller RH. Nanocrystals of poorly soluble drugs for oral administration. New Drugs Online 2003;5:20–2
- Lipinski CA. Poor aqueous solubility-an industry wide problem in ADME screening. Am Pharm Rev 2002;5:82–5
- Palmer AM. New horizons in drug metabolism, pharmacokinetics and drug discovery. Drug News Perspect 2003;16:57–62
- Noyes AA, Whitney WR. The rate of solution of solid substances in their own solutions. J Am Chem Soc 1897;19:930–4
- Kumar A, Sharma S, Kamble R. Self-emulsifyingdrug delivery system (SEDDS): future aspects. Int J Pharm Pharm Sci 2010;2:7–13
- Pouton CW. Lipid formulations for oral administration of drugs: non-emulsifying, self emulsifying and self micro-emulsifying drug delivery system. Eur J Pharm Sci 2000;11:93–8
- Kim HJ, Yoon KA, Hahn M, et al. Preparation and in vitro evaluation of self-microemulsifying drug delivery systems containing idebenone. Drug Dev Ind Pharm 2000;26:523–9
- Hauss DJ. Oral lipid-based formulations. Adv Drug Deliv Rev 2007;59:667–76
- Kommuru TR, Gurley B, Khan MA, et al. Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. Int J Pharm 2001;212:233–46
- Schott H. Surfactant systems: their chemistry, pharmacy and biology. J Pharm Sci 1985;74:1140–1
- Kishore RN, Yalavarthi PR, Vadlamudi HC, et al. Solid self microemulsification of Atorvastatin using hydrophilic carriers: a design. Drug Dev Ind Pharm 2014. [Epub ahead of print]. DOI: 10.3109/03639045.2014.938655
- Vithlani S, Sarraf S, Chaw CS. Formulation and in vitro evaluation of self-emulsifying formulations of Cinnarizine. Drug Dev Ind Pharm 2012;38:1188–94
- Hanh ND, Mitrevej A, Sathirakul K, et al. Development of phyllanthin-loaded self-microemulsifying drug delivery system for oral bioavailability enhancement. Drug Dev Ind Pharm 2013. [Epub ahead of print]. doi:10.3109/03639045.2013.858732
- Kang KB, Lee SJ, Chona KS, et al. Development of self micro mulsifying drug delivery systems for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm 2004;274:65–73
- McClelland GA, Stubbs RJ, Fix JA, et al. Enhancement of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor efficacy through administration of a controlled-porosity osmotic pump dosage form. Pharm Res 1991;8:873–6
- Cheng H, Sutton SC, Pipkin JD, et al. Evaluation of sustained/controlled-release dosage forms of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors in dogs and humans. Pharm Res 1993;10:1683–7
- Ginski MJ, Polli JE. Prediction of dissolution–absorption relationship from a dissolution/Caco-2 system. Int J Pharm 1999;177:117–25
- Le Ferrec E, Chesne C, Artusson P, et al. In vitro models of the intestinal barriers. Altern Lab Anim 2001;29:649–68
- Tukker JJ. In vitro methods for the assessment of permeability. In: Dressman JB, Lennernas H, eds. Oral drug absorption. New York: Marcel Dekker; 2000:51–72
- Kitaoka S, Hayashi H, Yokogoshi H, et al. Transmural potential changes associated with the in vitro absorption of theanine in the guinea pig intestine. Biosci Biotechnol Biochem 1996;60:1768–71
- Storkholm JH, Zhao J, Villadsen GE, et al. Spontaneous and bolus-induced motility in the chronically obstructed guinea-pig small intestine in vitro. Dig Dis Sci 2008;53:413–20
- Patel AR, Vavia PR. Preparation and in vivo evaluation of SMEDDS (Self-Microemulsifying Drug Delivery System) containing fenofibrate. Am Assoc Pharm Sci 2007;9:344–52
- Atef E, Belmonte AA. Formulation and in vitro and in vivo characterization of a phenytoin self-emulsifying drug delivery system (SEDDS). Eur J Pharm Sci 2008;35:257–63
- Patil P, Patil V, Paradkar A. Formulation of a self-emulsifying system for oral delivery of simvastatin: in vitro and in vivo evaluation. Acta Pharm 2007;57:111–22
- Nipun TS, Islam SMA. SEDDS of gliclazide: preparation and characterization by in-vitro, ex-vivo and in-vivo techniques. Saudi Pharm J 2014;22:343--8. Doi: 10.1016/j.jsps.2013.06.001